This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Heme oxygenase (HO), the rate-limiting enzyme in heme degradation, and its byproducts have antioxidative, antiapoptotic, anti-inflammatory, and cytoprotective properties. The expression of the inducible isoform, HO-1, in various tissues is increased in newborns, decreases toward adulthood, and may be of pivotal importance during the perinatal period. During pregnancy, it may mediate the regulation of maternal blood pressure, placental development, and vascularization, and, therefore, the maintenance of a healthy pregnancy. Pregnancy disorders, such as intrauterine growth restriction and preeclampsia, contribute significantly to preterm births as well as to perinatal morbidity and mortality and manifest even into adulthood. They stem from placental defects mediated by fetal genetic defects, maternal factors, or both. HO-1 has been shown to play a role in the maintenance of maternal inflammatory homeostasis and normal placental vasculature development by regulating angiogenesis and matrix remodeling in early pregnancy. Therefore, a genetic deficiency in HO-1 gene expression may be an underlying cause of pregnancy disorders, in particular, those attributed to placental dysfunction.
- BPD;
- bronchopulmonary dysplasia
- CO;
- carbon monoxide
- Het;
- heterozygote
- HO;
- heme oxygenase
- ORDP;
- oxygen radical diseases of prematurity
- SA;
- spiral artery
- uNK;
- uterine natural killer
- WT;
- wild-type
- Copyright © 2012 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.